HEALTH.2010.2.4.1-6
HEALTH.2010.2.4.1-6
6 projects · €17,924,575 total EU contribution (project-level) · 57 participating organizations · 13 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€17,924,575
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (14)
- Italy (9)
- Spain (8)
- CH (6)
- UK (5)
- France (4)
- SE (3)
- BE (2)
- US (2)
- HU (1)
- IL (1)
- Netherlands (1)
- PL (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III3 projects · ES
- THE UNIVERSITY OF LIVERPOOL3 projects · UK
- CR-UK2 projects · UK
- INT2 projects · IT
- IDIBELL-CERCA2 projects · ES
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2 projects · UK
- KU Leuven2 projects · BE
- UNITO2 projects · IT
- CSIC1 projects · ES
- ALTA SRLU1 projects · IT
- Apointech1 projects · ES
- Axcentua1 projects · SE
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Genomic predictors and oncogenic drivers in hepatocellular carcinoma HEPTROMIC · 259744 | FP7 | €2,999,478 | €3,942,897 | Details |
Targeting the tumour microenvironment to improve pancreatic cancer prognosis EPC-TM-NET · 256974 | FP7 | €3,000,000 | €4,230,298 | Details |
Integrating chemical approaches to treat pancreatic cancer: making new leads for a cure PANACREAS · 256986 | FP7 | €2,965,207 | €3,899,823 | Details |
Determining (epi)genetic therapeutic signatures for improving lung cancer prognosis CURELUNG · 258677 | FP7 | €2,965,749 | €3,849,117 | Details |
New approaches for the targeted therapy of Non-Small Cell Lung Cancer LUNGTARGET · 259770 | FP7 | €2,997,332 | €4,067,435 | Details |
Development of novel diagnostic and therapeutic approaches to improve patient outcome in lung and pancreatic tumours CANCERALIA · 259737 | FP7 | €2,996,809 | €4,155,433 | Details |